Seddon B, Mason D
Medical Research Council Cellular Immunology Unit, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.
J Exp Med. 1999 Jan 18;189(2):279-88. doi: 10.1084/jem.189.2.279.
Previous studies have shown that induction of autoimmune diabetes by adult thymectomy and split dose irradiation of PVG.RT1(u) rats can be prevented by their reconstitution with peripheral CD4(+)CD45RC-TCR-alpha/beta+RT6(+) cells and CD4(+)CD8(-) thymocytes from normal syngeneic donors. These data provide evidence for the role of regulatory T cells in the prevention of a tissue-specific autoimmune disease but the mode of action of these cells has not been reported previously. In this study, autoimmune thyroiditis was induced in PVG.RT1(c) rats using a similar protocol of thymectomy and irradiation. Although a cell-mediated mechanism has been implicated in the pathogenesis of diabetes in PVG.RT1(u) rats, development of thyroiditis is independent of CD8(+) T cells and is characterized by high titers of immunoglobulin (Ig)G1 antithyroglobulin antibodies, indicating a major humoral component in the pathogenesis of disease. As with autoimmune diabetes in PVG. RT1(u) rats, development of thyroiditis was prevented by the transfer of CD4(+)CD45RC- and CD4(+)CD8(-) thymocytes from normal donors but not by CD4(+)CD45RC+ peripheral T cells. We now show that transforming growth factor (TGF)-beta and interleukin (IL)-4 both play essential roles in the mechanism of this protection since administration of monoclonal antibodies that block the biological activity of either of these cytokines abrogates the protective effect of the donor cells in the recipient rats. The prevention of both diabetes and thyroiditis by CD4(+)CD45RC- peripheral cells and CD4(+)CD8(-) thymocytes therefore does not support the view that the mechanism of regulation involves a switch from a T helper cell type 1 (Th1) to a Th2-like response, but rather relies upon a specific suppression of the autoimmune responses involving TGF-beta and IL-4. The observation that the same two cytokines were implicated in the protective mechanism, whether thymocytes or peripheral cells were used to prevent autoimmunity, strongly suggests that the regulatory cells from both sources act in the same way and that the thymocytes are programmed in the periphery for their protective role. The implications of this result with respect to immunological homeostasis are discussed.
先前的研究表明,对PVG.RT1(u)大鼠进行成年胸腺切除术和分次剂量照射诱导自身免疫性糖尿病,可通过用来自正常同基因供体的外周CD4(+)CD45RC-TCR-α/β+RT6(+)细胞和CD4(+)CD8(-)胸腺细胞对其进行重建来预防。这些数据为调节性T细胞在预防组织特异性自身免疫性疾病中的作用提供了证据,但这些细胞的作用方式此前尚未见报道。在本研究中,采用类似的胸腺切除术和照射方案在PVG.RT1(c)大鼠中诱导自身免疫性甲状腺炎。尽管细胞介导机制与PVG.RT1(u)大鼠糖尿病的发病机制有关,但甲状腺炎的发展不依赖于CD8(+)T细胞,其特征是高滴度的免疫球蛋白(Ig)G1抗甲状腺球蛋白抗体,表明疾病发病机制中存在主要的体液成分。与PVG.RT1(u)大鼠的自身免疫性糖尿病一样,正常供体的CD4(+)CD45RC-和CD4(+)CD8(-)胸腺细胞的转移可预防甲状腺炎的发展,但CD4(+)CD45RC+外周T细胞则不能。我们现在表明,转化生长因子(TGF)-β和白细胞介素(IL)-4在这种保护机制中均发挥重要作用,因为给予阻断这两种细胞因子中任何一种生物活性的单克隆抗体都会消除供体细胞对受体大鼠的保护作用。因此,CD4(+)CD45RC-外周细胞和CD4(+)CD8(-)胸腺细胞对糖尿病和甲状腺炎的预防并不支持调节机制涉及从1型辅助性T细胞(Th1)向Th2样反应转变的观点,而是依赖于涉及TGF-β和IL-4的自身免疫反应的特异性抑制。无论使用胸腺细胞还是外周细胞来预防自身免疫,相同的两种细胞因子都参与保护机制这一观察结果强烈表明,来自这两种来源的调节性细胞以相同方式发挥作用,并且胸腺细胞在外周被编程以发挥其保护作用。讨论了该结果对免疫稳态的影响。